Skip to content
zameds

Drospirenone, ethinylestradiol

Sold as Yasmin, Yaz, Ruby, Jarina, Ynez, Cloelle, Eloine, Maya, Yade, Drasira, Drospirenone/ethinylestradiol adco, Ethodros, Nezdropaz, Uvisma forte, Uvisma, Debigen, Ginorelle, Contrez, Contrezin, Rubaz, Esdopil

S4Read from the PI-PIL document and verified

Combination product

This product contains more than one active ingredient, so it has no single molecular structure.

Background

Loading...
Loading Wikipedia summary

Registration

Applicants
9
Registrations
21
Schedule source
SAHPRA documentation

Applicants and registrations

ApplicantBrandsDosagesRegistrationsScheduleLeaflets
Bayer (Pty) Ltd û IsandoCertificate held by Bayer (Pty) Ltd, BayerYasmin, Yaz, Jarina, Eloine3mg, 3 mg/0,03 mg, 3 mg340494, 410842, 430782, 440957S4S3 to S4 by packPIPIL
Pharma Dynamics (Pty) LtdRuby, Rubaz3 mg/0,03 mg, 3 mg / 0,02 mg430648, 50342S4S3 to S4 by packPIPIL
Adcock ingram limited3 of 5 cancelledYnez, Cloelle, Drospirenone/ethinylestradiol adco, Ethodros, Nezdropaz3/0,02 MG440397, 440398, 470702, 470704, 470705Not determinedNone
Teva Pharmaceuticals (Pty) LtdCancelledMaya, YadeNot stated470024, 470025Not determinedNone
Cipla Medpro (Pty) LtdDrasira, GinorelleNot stated470141, 500343Not determinedNone
Ranbaxy (SA) (Pty) LtdCancelledUvisma forte, UvismaNot stated481025, 481026Not determinedNone
Viatris South Africa (Pty) LtdDebigenNot stated481252Not determinedNone
Innovata pharmaceuticalsCertificate held by Innovata Pharmaceuticals (Pty) LtdContrez, Contrezin0,02 mg, 3,0 mg, 0,03 mg, 3,0 mg500517, 500590Not determinedPIPIL
Austell Pharmaceuticals (Pty) LtdEsdopil0,03 mg 3/0,550861Not determinedNone

Variants

ProductStrength and formRegistrationStatusScheduleLeaflets
Yasmin

EACH TABLET CONTAINS DROSPIRENONE 3,0 mg ETHINYLESTRADIOL 0,03 mg

3mgTablet34049434/18.8/0494Approved 11 July 2024RegisteredS3PIPIL
Yaz

EACH PACK CONTAINS DROSPIRENONE 3,0 mg ETHINYLESTRADIOL 0,02 mg

3mgTablet41084241/21.8.2/0842Approved 11 October 2013RegisteredS4PIPIL
Ruby

EACH TABLET CONTAINS DROSPIRENONE 3.0 mg ETHINYLESTRADIOL 0,03 mg

3 mg/0,03 mgFilm-coated tablets43064843/18.8/0648Approved 18 October 2024RegisteredS3PIPIL
Jarina

EACH TABLET CONTAINS DROSPIRENONE 3,0 mg ETHINYLESTRADIOL 0,03 mg

3 mg/0,03 mgFilm-coated tablets.43078243/18.8/0782Approved 11 July 2024RegisteredS3PIPIL
Ynez

EACH TABLET CONTAINS DROSPIRENONE 3,0 mg ETHINYLESTRADIOL 0,03 mg

Not listed44039744/18.8/0397RegisteredNot determinedNone
Cloelle

EACH TABLET CONTAINS DROSPIRENONE 3,0 mgETHINYLESTRADIOL 0,03 mg

Not listed44039844/18.8/0398CancelledNot determinedNone
Eloine

EACH TABLET CONTAINS DROSPIRENONE 3,0 mg ETHINYLESTRADIOL 0,02 mg

3 mgFilm-coated tablets44095744/21.8.2/0957Approved 10 October 2023RegisteredS4PIPIL
Maya

EACH TABLET CONTAINS : DROSPIRENONE 3,0 mg ETHINYLESTRADIOL 0,03 mg

Not listed47002447/21.8.2/0024CancelledNot determinedNone
Yade

EACH TABLET CONTAINS : DROSPIRENONE 3,0 mg ETHINYLESTRADIOL 0,02 mg

Not listed47002547/21.8.2/0025CancelledNot determinedNone
Drasira

Each tablet contains DROSPIRENONE 3,0 mg and ETHINYLESTRADIOL 0,02 mg

Not listed47014147/21.8.2/0141RegisteredNot determinedNone
Drospirenone/ethinylestradiol 3/0,02 MG adco

Each active tablet contains DROSPIRENONE 3,0 mg AND ETHINYLESTRADIOL 0,02 mg

3/0,02 MG47070247/21.8.2/0702CancelledNot determinedNone
Ethodros

Each active tablet contains DROSPIRENONE 3,0 mg AND ETHINYLESTRADIOL 0,02 mg

Not listed47070447/21.8.2/0704RegisteredNot determinedNone
Nezdropaz

Each active tablet contains DROSPIRENONE 3,0 mg AND ETHINYLESTRADIOL 0,02 mg

Not listed47070547/21.8.2/0705CancelledNot determinedNone
Uvisma forte

Each active tablet contains DROSPIRENONE 3,0 mg and ETHINYLESTRADIOL 0,03 mg

Not listed48102548/18.8/1025CancelledNot determinedNone
Uvisma

Each active tablet contains DROSPIRENONE 3,0 mg and ETHINYLESTRADIOL 0,02 mg

Not listed48102648/21.8.2/1026CancelledNot determinedNone
Debigen

Each active tablet contains DROSPIRENONE 3,0 mg ETHINYLESTRADIOL 0,02 mg

Not listed48125248/21.18.2/1252RegisteredNot determinedNone
Ginorelle

Each active tablet contains DROSPIRENONE 3,0 mg and ETHINYLESTRADIOL 0,03 mg

Not listed50034350/18.8/0343RegisteredNot determinedNone
Contrez

EACH TABLET CONTAINS ETHINYLESTRADIOL 0.02 mg and DROSPIRENONE 3,0 mg

0,02 mg, 3,0 mgTablet50051750/21.8.2/0517Approved 25 October 2022RegisteredNot determinedPIPIL
Contrezin

ETHINYLESTRADIOL & DROSPIRENONE

0,03 mg, 3,0 mgTablet50059050/21.8.2/0590Approved 2 September 2025RegisteredNot determinedPIPIL
Rubaz

Each active tablet contains DROSPIRENONE 3,00 mg ETHINYLESTRADIOL 0,02 mg

3 mg / 0,02 mgFilm-coated tablets5034250/21.8.2/0342Approved 21 January 2025RegisteredS4PIPIL
Esdopil 3/0,0,03 MG

EACH TABLET CONTAINS DROSPIRENONE 3,0 mg ETHINYLESTRADIOL 0,03 mg

0,03 mg 3/0,55086155/18.8/0861RegisteredNot determinedNone

Regulatory status

Where S4 sits on the scale

Prescription-only medicine.

Schedule 4 covers most ordinary prescription medicines. You need a prescription from an authorised prescriber, such as a doctor or dentist, and a pharmacist dispenses it. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.

Schedule S4, read from the product's PI-PIL leaflet.

Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

SAHPRA documents

Schedule verified from official documents

Schedule Verification

Yasmin, Bayer (Pty) Ltd û Isando is scheduled S3 in its official SAHPRA documents, read with 90% confidence.

Professional information (PI)For healthcare professionalsYasmin, Bayer (Pty) Ltd û IsandoPatient information leaflet (PIL)For patients and carersYasmin, Bayer (Pty) Ltd û Isando

These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.

Research articles

Loading...
Loading PubMed articles